Medical/Pharmaceuticals News & Press Release Distribution

CAS collaborates with Microsoft to enable faster innovation in pharmaceutical, life sciences, and chemical industries

CAS ConnectionsSM integrates trusted human-curated scientific knowledge into Microsoft Copilot COLUMBUS, Ohio, Oct. 20, 2026 /PRNewswire/ -- CAS, a division of the American Chemical Society, today announced the availability of CAS Connections in Microsoft Copilot. The connector gives Copilot cus...

2026-10-20 20:00 2158

NeuroXT Inc. Receives U.S. FDA 510(k) Clearance for NEXT-Cue, AI Software Supporting Prognostic Assessment in Mild Cognitive Impairment

* Supports clinicians in assessing progression from mild cognitive impairment to Alzheimer's dementia within five years * NeuroXT Inc. to advance U.S. commercialization and adoption by healthcare institutions following FDA 510(k) clearance SEOUL, South Korea, Oct. 20, 2026 /PRNewswire/ -- Neu...

2026-10-20 20:00 2125

Hospital Authority appreciates generous donation from Sino Group and Ng Teng Fong Charitable Foundation

HONG KONG, Oct. 20, 2026 /PRNewswire/ -- The Hospital Authority (HA) today (October 20) extends its heartfelt gratitude to Sino Group and Ng Teng Fong Charitable Foundation for their generous donation of a combined total of $30 million to support the establishment of two operating theatres dedica...

2026-10-20 18:55 2711

Hospital Authority appreciates generous donation from Sino Group and Ng Teng Fong Charitable Foundation

QVAXB40 Initiative Expands Access to PeKa Sihat Health Screening Across Malaysia

Collaboration pledges up to 100,000 free influenza vaccines as an entry point to preventive health screening for underserved B40 communities. PETALING JAYA, Malaysia, Oct. 20, 2026 /PRNewswire/ -- Qualitas Medical Group Sdn. Bhd. ("Qualitas") and ProtectHealth Corporation Sdn. Bhd. ("ProtectHeal...

2026-10-20 17:50 2448

QVAXB40 Initiative Expands Access to PeKa Sihat Health Screening Across Malaysia

New Innovative Molecular Technology Combination "LAMP + CRISPR" as CE-IVD

A Collaboration Leads to Molecularbiological Innovation MUNICH, Oct. 20, 2026 /PRNewswire/ -- AmplexDiagnostics and Scope Biosciences are proud to introduce a groundbreaking solution in molecular diagnostics. In a new approach, "eazySNP" combines the highly specialized molecular technologies LAM...

2026-10-20 14:10 1708

New Innovative Molecular Technology Combination "LAMP + CRISPR" as CE-IVD

A Collaboration Leads to Molecularbiological Innovation MUNICH, Oct. 20, 2026 /PRNewswire/ -- AmplexDiagnostics and Scope Biosciences are proud to introduce a groundbreaking solution in molecular diagnostics. In a new approach, "eazySNP" combines the highly specialized molecular technologies LAM...

2026-10-20 14:10 1273

Sisram Medical Announces NMPA Acceptance of Profhilo Registration Application for Facial Indication

Advancing Commercialization Preparations to Expand Injectables Presence in China HONG KONG, Oct. 19, 2026 /PRNewswire/ -- Sisram Medical Ltd (the "Company" or "Sisram", 1696.HK), a global wellness group offering Energy-Based Devices ("EBD"), injectables, and other complementary solutions, today a...

2026-10-20 09:00 2631

Colossal to Repatriate Rare Moa Egg to Aotearoa (New Zealand)

Colossal secured one of the world's few surviving moa eggs and will entrust it to New Zealand-based moa de-extinction program partners, to ensure the egg returns to its rightful land and people. CHRISTCHURCH, New Zealand and DALLAS, Oct. 20, 2026 /PRNewswire/ -- Colossal Biosciences, the world's...

2026-10-20 08:18 2347

Colossal to Repatriate Rare Moa Egg to Aotearoa (New Zealand)

Distinguished clinician-scientist Professor Marcus Ong is first Singaporean emergency medicine physician elected to National Academy of Medicine, USA

SINGAPORE, Oct. 20, 2026 /PRNewswire/ -- Professor Marcus Ong Eng Hock, Senior Consultant, Department of Emergency Medicine, Singapore General Hospital (SGH), has become the first Emergency Medicine specialist from Singapore to be elected to the United States National Academy of Medicine (NAM). H...

2026-10-20 08:15 4170

Distinguished clinician-scientist Professor Marcus Ong is first Singaporean emergency medicine physician elected to National Academy of Medicine, USA

Ascletis Announces Positive Preclinical Data for the Most Comprehensive Once-Weekly Oral Peptide Pipeline for the Treatment of Obesity

- Ascletis' industry-leading once-weekly oral peptide pipeline covers all four validated targets, with multiple first-in-class fixed-dose combinations. - ASC36o, a once-weekly oral amylin receptor peptide agonist, is the most advanced drug candidate of Ascletis' once-weekly oral peptide p...

2026-10-20 08:10 3913

Frost & Sullivan awards WuXi AppTec with 2026 Global Company of the Year Recognition for CRDMO Leadership

Integrated capabilities, global capacity, and customer-centric innovation strengthen WuXi AppTec's position in the evolving contract research, development, and manufacturing (CRDMO) landscape. SAN ANTONIO, Oct. 20, 2026 /PRNewswire/ -- Frost & Sullivan

2026-10-20 08:00 2597

WuXi AppTec Receives Frost & Sullivan's Global Company of the Year Recognition in CRDMO for Tenth Consecutive Year

SHANGHAI, Oct. 19, 2026 /PRNewswire/ -- WuXi AppTec, a leading global pharmaceutical CRDMO (Contract Research, Development, and Manufacturing Organization), has received Frost & Sullivan's 2026 Global Company of the Year Recognition in the CRDMO industry for the tenth consecutive year. Frost & S...

2026-10-20 08:00 3403

Versiti becomes 10th U.S. blood center to adopt FDA-cleared automation from Terumo Blood and Cell Technologies

Automated whole blood processing will expand platelet production capacity and help meet growing hospital demand LAKEWOOD, Colo. and MILWAUKEE, Oct. 19, 2026 /PRNewswire/ -- Versiti has become the 10th U.S. blood center to adopt the Reveos™ Automated Blood Processing System

2026-10-19 22:00 4819

Alloop Joins CaringKind's 38th Annual Alzheimer's Walk and Brain Health Day

NEW YORK, Oct. 19, 2026 /PRNewswire/ -- Alloop participated in CaringKind's 38th Annual Alzheimer's Walk and Brain Health Day in Central Park on October 17. The team joined the walk and hosted an on-site booth alongside people living with Alzheimer's disease and related demen...

2026-10-19 21:00 1500

Alloop Joins CaringKind's 38th Annual Alzheimer's Walk and Brain Health Day

Bambusa Therapeutics Presents Detailed BBT001 Atopic Dermatitis Proof-of-Concept Results at ISAD 2026

Detailed findings from a randomized, double-blind, placebo-controlled cohort presented by Eric Simpson, M.D., M.C.R., of Oregon Health & Science University Presentation brings previously announced clinical findings together with pharmacokinetic and biomarker evidence for scientific discussion Ba...

2026-10-19 21:00 2934

POMDOCTOR LIMITED Announces the Termination of Its ADR Program and Trade Class A Ordinary Shares on Nasdaq

GUANGZHOU, China, Oct. 19, 2026 /PRNewswire/ -- POMDOCTOR LIMITED ("Pomdoctor" or the "Company") (NASDAQ: POM), a digital healthcare company focused on advancing artificial intelligence ("AI")-enabled healthcare solutions, today announced that it has commenced to terminate its American Depositary...

2026-10-19 20:30 5744

Transcenta Therapeutics Announces Appointment of Ms. Jennie Ma as Chief Financial Officer

SUZHOU, China and PRINCETON, N.J., Oct. 19, 2026 /PRNewswire/ -- Transcenta Therapeutics (HKEX: 06628) today announced that its Board of Directors has approved the appointment of Ms. Jennie Ma as Chief Financial Officer (CFO) of the Company. In this role, Ms. Ma will oversee the Company's financi...

2026-10-19 20:00 2396

Akeso Announces Opening of Global Phase II Study of Ivonescimab in First-Line Clear Cell Renal Cell Carcinoma, Including Combination with Cadonilimab

HONG KONG, Oct. 19, 2026 /PRNewswire/ -- Akeso, Inc. (9926.HK) ("Akeso" or the "Company") and its partner Summit TherapeuticsInc. jointly announced an international multicenter Phase II clinical study (SMT112-216 / AK112-216 / NCT07877194). Built on Akeso's first-in-class immuno-oncology (IO) c...

2026-10-19 19:59 2447

OncoC4 Announces NMPA Acceptance of Two IND Applications for Cesalatamig Combination Studies with ADCs and Pan-RAS Inhibitors

— New Studies Expand Cesalatamig into Biomarker-driven Precision Immuno-oncology Strategies — Cesalatamig is Also Being Evaluated in Ongoing Phase 2 Studies in the United States and in China ROCKVILLE, Md. , Oct. 19, 2026 /PRNewswire/ -- OncoC4 Inc., a late clinical-stage biopharmaceutical co...

2026-10-19 19:16 2201

Telix and Ekalia to Collaborate on Astatine-211 Production in the U.S.

* Collaboration establishes a framework for a dedicated U.S. source of astatine-211 (211At), a scarce, next-generation alpha-emitting isotope with significant potential in targeted alpha therapy (TAT). * Secures long-term, priority isotope access for Telix's alpha therapy pipeline, including ...

2026-10-19 13:30 2560